RNV Stock Overview
A medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
ReNerve Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.14 |
| 52 Week High | AU$0.20 |
| 52 Week Low | AU$0.13 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -23.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| RNV | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -3.3% | -1.1% | -2.7% |
| 1Y | n/a | 0.4% | 6.5% |
Return vs Industry: Insufficient data to determine how RNV performed against the Australian Medical Equipment industry.
Return vs Market: Insufficient data to determine how RNV performed against the Australian Market.
Price Volatility
| RNV volatility | |
|---|---|
| RNV Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.8% |
| 10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: RNV's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine RNV's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Julian Chick | renerve.com.au |
ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures. It develops NervAlign Nerve Cuff, a protective wrap used to protect repaired injured nerves; NervAlign Nerve Graft, a size-based range of off-the-shelf nerve grafts for the repair of damaged nerves; and NervAlign bionic nerve to produce a replacement nerve that contains shaped ionic polymers, which would enable the stimulation of the distal end of a nerve injury. The company was incorporated in 2016 and is headquartered in Northcote, Australia.
ReNerve Limited Fundamentals Summary
| RNV fundamental statistics | |
|---|---|
| Market cap | AU$20.57m |
| Earnings (TTM) | -AU$2.98m |
| Revenue (TTM) | AU$177.37k |
116.0x
P/S Ratio-6.9x
P/E RatioIs RNV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RNV income statement (TTM) | |
|---|---|
| Revenue | AU$177.37k |
| Cost of Revenue | AU$623.00 |
| Gross Profit | AU$176.75k |
| Other Expenses | AU$3.16m |
| Earnings | -AU$2.98m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.021 |
| Gross Margin | 99.65% |
| Net Profit Margin | -1,682.86% |
| Debt/Equity Ratio | 0% |
How did RNV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 22:19 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ReNerve Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|